Thomas H. King

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Single-Shot ChAd3-MARV Vaccine in Modified Formulation Buffer Shows 100% Protection of NHPs”.

Single-Shot ChAd3-MARV Vaccine in Modified Formulation Buffer Shows 100% Protection of NHPs

Vaccines(2022)10.3390/vaccines10111935

N/A

0DataRank · unranked

14 citations

Thomas H. King, Kendra J. Alfson, Katie A. Albanese, Julianne Smith, Paul Smock +14 more

Bridging Animal and Human Data in Pursuit of Vaccine Licensure

Vaccines(2022)10.3390/vaccines10091384

N/A

0DataRank · unranked

13 citations

William E. Dowling, Thomas H. King, Christian Martinez, Bai V. Nguyen, Ramon Roozendaal +6 more

Safety, tolerability, immunogenicity, and plasmapheresis-based antibody collection in a phase 1b open label trial of two investigational monovalent chimpanzee adenoviral vectored filovirus vaccines, cAd3-Sudan and cAd3-Marburg, in healthy adults

EBioMedicine(2025)10.1016/j.ebiom.2025.105889

N/A

0DataRank · unranked

1 citations

Michael Stevenson, Roxana Rustomjee, Courtney L. Finch, Jocelyn Jakubik, Thomas H. King +1 more